Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Vitamin D3 supplementation in HIV infection: effectiveness and associations with antiretroviral therapy.

Coelho L, Cardoso SW, Luz PM, Hoffman RM, Mendonça L, Veloso VG, Currier JS, Grinsztejn B, Lake JE.

Nutr J. 2015 Aug 18;14:81. doi: 10.1186/s12937-015-0072-6.

2.

Vitamin D supplementation and antibacterial immune responses in adolescents and young adults with HIV/AIDS.

Chun RF, Liu NQ, Lee T, Schall JI, Denburg MR, Rutstein RM, Adams JS, Zemel BS, Stallings VA, Hewison M.

J Steroid Biochem Mol Biol. 2015 Apr;148:290-7. doi: 10.1016/j.jsbmb.2014.07.013. Epub 2014 Aug 1. Review.

PMID:
25092518
3.

High-dose vitamin D3 supplementation in children and young adults with HIV: a randomized, placebo-controlled trial.

Stallings VA, Schall JI, Hediger ML, Zemel BS, Tuluc F, Dougherty KA, Samuel JL, Rutstein RM.

Pediatr Infect Dis J. 2015 Feb;34(2):e32-40. doi: 10.1097/INF.0000000000000483.

4.

Vitamin D deficiency and altered bone mineral metabolism in HIV-infected individuals.

Eckard AR, McComsey GA.

Curr HIV/AIDS Rep. 2014 Sep;11(3):263-70. doi: 10.1007/s11904-014-0218-8. Review.

5.

Determination of optimal vitamin D3 dosing regimens in HIV-infected paediatric patients using a population pharmacokinetic approach.

Foissac F, Meyzer C, Frange P, Chappuy H, Benaboud S, Bouazza N, Friedlander G, Souberbielle JC, Urien S, Blanche S, Tréluyer JM.

Br J Clin Pharmacol. 2014 Nov;78(5):1113-21. doi: 10.1111/bcp.12433.

6.

Vitamin D insufficiency and subclinical atherosclerosis in non-diabetic males living with HIV.

Portilla J, Moreno-Pérez O, Serna-Candel C, Escoín C, Alfayate R, Reus S, Merino E, Boix V, Giner L, Sánchez-Payá J, Picó A.

J Int AIDS Soc. 2014 May 13;17:18945. doi: 10.7448/IAS.17.1.18945. eCollection 2014.

7.

Change in vitamin d levels occurs early after antiretroviral therapy initiation and depends on treatment regimen in resource-limited settings.

Havers FP, Detrick B, Cardoso SW, Berendes S, Lama JR, Sugandhavesa P, Mwelase NH, Campbell TB, Gupta A; ACTG A5175 PEARLS and NWCS319 Study Teams.

PLoS One. 2014 Apr 21;9(4):e95164. doi: 10.1371/journal.pone.0095164. eCollection 2014.

8.

Vitamin D status of human immunodeficiency virus-positive patients with advanced liver disease enrolled in the solid organ transplantation in HIV: multi-site study.

Branch AD, Barin B, Rahman A, Stock P, Schiano TD.

Liver Transpl. 2014 Feb;20(2):156-64. doi: 10.1002/lt.23784. Epub 2013 Dec 12.

9.

Per oral substitution with 300000 IU vitamin D (Cholecalciferol) reduces bone turnover markers in HIV-infected patients.

Piso RJ, Rothen M, Rothen JP, Stahl M, Fux C.

BMC Infect Dis. 2013 Dec 6;13:577. doi: 10.1186/1471-2334-13-577.

10.

Prevalence and Factors Associated with Vitamin D Deficiency and Hyperparathyroidism in HIV-Infected Patients Treated in Barcelona.

Lerma E, Molas ME, Montero MM, Guelar A, González A, Villar J, Diez A, Knobel H.

ISRN AIDS. 2012 Jul 12;2012:485307. doi: 10.5402/2012/485307. eCollection 2012.

11.

Vitamin D-related host genetic variants alter HIV disease progression in children.

Moodley A, Qin M, Singh KK, Spector SA.

Pediatr Infect Dis J. 2013 Nov;32(11):1230-6. doi: 10.1097/INF.0b013e31829e4d06.

12.

Cross-sectional study of vitamin D levels, immunologic and virologic outcomes in HIV-infected adults.

Bearden A, Abad C, Gangnon R, Sosman JM, Binkley N, Safdar N.

J Clin Endocrinol Metab. 2013 Apr;98(4):1726-33. doi: 10.1210/jc.2012-4031. Epub 2013 Mar 1.

13.

Vitamin D attenuates nucleoside reverse transcriptase inhibitor induced human skeletal muscle mitochondria DNA depletion.

Campbell GR, Pallack ZT, Spector SA.

AIDS. 2013 Jun 1;27(9):1397-401. doi: 10.1097/QAD.0b013e32836010dd.

14.

Physiologic frailty and fragility fracture in HIV-infected male veterans.

Womack JA, Goulet JL, Gibert C, Brandt CA, Skanderson M, Gulanski B, Rimland D, Rodriguez-Barradas MC, Tate J, Yin MT, Justice AC; Veterans Aging Cohort Study Project Team.

Clin Infect Dis. 2013 May;56(10):1498-504. doi: 10.1093/cid/cit056. Epub 2013 Feb 1.

15.

Severe hypovitaminosis D correlates with increased inflammatory markers in HIV infected patients.

Ansemant T, Mahy S, Piroth C, Ornetti P, Ewing S, Guilland JC, Croisier D, Duvillard L, Chavanet P, Maillefert JF, Piroth L.

BMC Infect Dis. 2013 Jan 7;13:7. doi: 10.1186/1471-2334-13-7.

16.

Vitamin D Levels, Natural H1N1 Infection and Response to H1N1 Vaccine among HIV-Infected Individuals.

Momplaisir F, Frank I, Meyer W 3rd, Kim D, Kappes R, Tebas P.

J AIDS Clin Res. 2012 May 20;3(4):152.

17.

Vitamin D insufficiency may impair CD4 recovery among Women's Interagency HIV Study participants with advanced disease on HAART.

Aziz M, Livak B, Burke-Miller J, French AL, Glesby MJ, Sharma A, Young M, Villacres MC, Tien PC, Golub ET, Cohen MH, Adeyemi OM.

AIDS. 2013 Feb 20;27(4):573-8. doi: 10.1097/QAD.0b013e32835b9ba1.

18.

Vitamin D3 supplementation scheme in HIV-infected patients based upon pharmacokinetic modelling of 25-hydroxycholecalciferol.

Foissac F, Tréluyer JM, Souberbielle JC, Rostane H, Urien S, Viard JP.

Br J Clin Pharmacol. 2013 May;75(5):1312-20. doi: 10.1111/bcp.12006.

19.

Vitamin D rescues impaired Mycobacterium tuberculosis-mediated tumor necrosis factor release in macrophages of HIV-seropositive individuals through an enhanced Toll-like receptor signaling pathway in vitro.

Anandaiah A, Sinha S, Bole M, Sharma SK, Kumar N, Luthra K, Li X, Zhou X, Nelson B, Han X, Tachado SD, Patel NR, Koziel H.

Infect Immun. 2013 Jan;81(1):2-10. doi: 10.1128/IAI.00666-12. Epub 2012 Oct 15.

20.

The effect of tenofovir on vitamin D metabolism in HIV-infected adults is dependent on sex and ethnicity.

Klassen K, Martineau AR, Wilkinson RJ, Cooke G, Courtney AP, Hickson M.

PLoS One. 2012;7(9):e44845. doi: 10.1371/journal.pone.0044845. Epub 2012 Sep 12.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk